W hat is the cost of an adverse event? This question, which now underpins many quality improvement efforts, initially interested only medical tort litigators and their clients. In 1991, the Harvard Medical Practice Study I was one of the first systematic attempts to measure the frequency of health care-related adverse events among hospital inpatients. 1 In that seminal study, researchers reviewed patient charts for evidence of adverse events "caused by medical care." Their approach was soon replicated in the United Kingdom, Australia and New Zealand. 2 While the Harvard study's initial focus was on identifying negligence, the field evolved to highlight incidents that were potentially preventable. 3,4 In 2014, the landmark Canadian Adverse Events Study reported adverse events in 7.5% of hospital admissions, with 37% of these events deemed preventable. 5 A decade later, the Canadian Institute for Health Information (CIHI) and the Canadian Patient Safety Institute developed algorithms to identify adverse events using health administrative data (www.cihi.ca/sites/default/files/document/hospital_harm_ summary_en.pdf). It paved the way for scaled, reproducible measurements of adverse events in Canada. The authors of the CIHI report estimated that $685 million was spent Canada-wide in 2014-2015 on hospital-based adverse events; however, no detailed costing analysis was included in the report. A linked study provides estimates of the health system impact of "hospital harm," as identified using CIHI's algorithms. 6 Using health administrative data for almost half a million patients in Ontario over a 1-year period (2015-2016), Tessier and colleagues estimated that hospital harm occurred in 5.9% of admissions. The authors compared the length and cost of patient-centred episodes of care (PCEs) for patients who did and did not experience hospital harm. 6 A PCE included all hospital-and communitybased medical care, including home care and long-term care, that occurred in the 30 days after discharge from hospital. Across all types of admissions-and after adjusting for sociodemographic variables, type of hospital admission, measures of comorbidity and previous health care usage-admissions to hospital during which harm occurred were a week longer, the PCEs were more than 2 weeks longer and costs were substantially more than for no-harm scenarios. 6